Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2007; 13(3): 383-390
Published online Jan 21, 2007. doi: 10.3748/wjg.v13.i3.383
Published online Jan 21, 2007. doi: 10.3748/wjg.v13.i3.383
Accession No. | Gene Name | Description | CC1 |
NM_002646 | PIK3C2B2 | Phosphoinositide-3-kinase, class 2, beta polypeptide | 0.60 |
NM_152270 | NM_1522702 | Hypothetical protein FLJ34922 (FLJ34922) | 0.59 |
NP113470 | NP113470 | Unknown | 0.58 |
AK024488 | AK024488 | FLJ00087 protein | 0.57 |
AB064167 | AB064167 | IGL mRNA for immunoglobulin lambda light chain VLJ region | 0.57 |
BC015833 | BC015833 | cDNA clone MGC:27152 IMAGE:4691630 | 0.57 |
A_23_P32661 | A_23_P32661 | Unknown | 0.57 |
M35730 | M35730 | MHC class II DQ3.1ER (DR4) | 0.56 |
NP077661 | NP077661 | Unknown | 0.56 |
D29642 | D29642 | KIAA0053 | 0.56 |
NM_001778 | CD48 | CD48 antigen (B-cell membrane protein) | 0.56 |
NM_006144 | GZMA | Granzyme A (granzyme 1, cytotoxic) T-lymphocyte-associated serine esterase 3) | 0.56 |
NM_002125 | HLA-DRB5 | MHC class II, DR beta 5 | 0.55 |
NM_001803 | CDW52 | CDW52 antigen (CAMPATH-1 antigen) | 0.55 |
NP649772 | NP649772 | Unknown | 0.54 |
THC1889877 | THC1889877 | Unknown | 0.54 |
AX721203 | AX721203 | Sequence 163 from Patent WO0220754 | 0.54 |
BC036926 | BC0369262 | cDNA clone MGC:46491 IMAGE:5225843 | 0.54 |
M13975 | M13975 | Protein kinase C beta-II type (PRKCB1) | 0.53 |
AF035024 | AF035024 | MCE11H myosin-reactive immunoglobulin heavy chain variable region | 0.53 |
NM_033503 | BMF | Bcl2 modifying factor (BMF), mRNA | 0.53 |
A_23_P124264 | A_23_P124264 | Unknown | 0.53 |
U96396 | U96396 | Anti-streptococcal/anti-myosin immunoglobulin kappa light chain variable region | 0.53 |
A_23_P435390 | A_23_P435390 | Unknown | 0.53 |
A_23_P9854 | A_23_P9854 | Unknown | 0.52 |
AF490771 | AF490771 | MHC class II antigen (HLA-DRB1) mRNA, HLA-DRB1*1401 allele | 0.52 |
NM_002121 | HLA-DPB1 | MHC class II, DP beta 1 | 0.52 |
L03178 | L03178 | Cell-type T-cell immunoglobulin gamma chain, V region (IGHV@) | 0.52 |
NM_170744 | UNC5B | Unc-5 homolog B (C. elegans) | 0.51 |
S65186 | S651862 | EMT=T-cell-specific tyrosine kinase | 0.51 |
NM_022555 | HLA-DRB3 | MHC class II, DR beta 3 | 0.51 |
NM_001175 | ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.51 |
NM_002118 | HLA-DMB | MHC class II, DM beta | 0.51 |
NM_002838 | PTPRC | Protein tyrosine phosphatase, receptor type, C | 0.51 |
L34102 | L34102 | MHC class II HLA-DQB1*0502 | 0.51 |
AB020689 | AB020689 | KIAA0882 protein | 0.51 |
NM_002341 | LTB | Lymphotoxin beta (TNF superfamily, member 3) | 0.50 |
AJ297586 | AJ297586 | MHC class II antigen (HLA-DRB1 gene), DRB1*0402 allele | 0.50 |
NM_033554 | HLA-DPA1 | MHC class II, DP alpha 1 | 0.50 |
- Citation: Utsunomiya T, Okamoto M, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Aishima S, Yoshikawa Y, Hanai T, Inoue H, Barnard GF, Mori M. A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease. World J Gastroenterol 2007; 13(3): 383-390
- URL: https://www.wjgnet.com/1007-9327/full/v13/i3/383.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i3.383